We are live on
!
Find out more
ZVSA
ZyVersa Therapeutics
ZVSA
ZVSA
Delisted
ZVSA was delisted on the 16th of July, 2025.
5 hedge funds and large institutions have $273K invested in ZyVersa Therapeutics in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
150% more funds holding
Funds holding: 2 → 5 (+3)
121% more capital invested
Capital invested by funds: $124K → $273K (+$150K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Holders
5
Holders Change
+3
Holders Change %
+150%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$83.8K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$35.9K |
| 3 |
WAG
Winthrop Advisory Group
Boston,
Massachusetts
|
+$28.4K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$9.72K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6.73K |
Top Sellers
| 1 |
CL
CSS LLC
Chicago,
Illinois
|
-$23K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Goldman Sachs
New York
| $200K | +$83.8K | +112 | +61% |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $32.6K | +$35.9K | +48 | New |
|
|
WAG
3
Winthrop Advisory Group
Boston,
Massachusetts
| $25.8K | +$28.4K | +38 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $9K | +$9.72K | +13 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $6.33K | +$6.73K | +9 | New |
|
6
Wells Fargo
San Francisco,
California
| $54 | – | – | – |
|
|
CL
7
CSS LLC
Chicago,
Illinois
| – | -$23K | -42 | Closed |
|